2051 RINGWOOD AVENUE, SAN JOSE, CA
CFO Appointment - Nicholas M. Maestas Named Chief Financial Officer
Annual Meeting Vote Results - Rani Therapeutics Holdings, Inc.
Reports First Quarter 2026 Financial Results; Provides Corporate Update; Announces CFO Transition
Financial Results, Press Release
Termination of Tax Receivable Agreement with InCube Labs, LLC
Material disclosure
Rani Therapeutics Enters $42.6M Securities Purchase Agreement
Q1
FY 2025
Q3
Q2
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Notice of Exempt Offering of Securities
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Information Statement
Preliminary Information Statement
Definitive Proxy Statement
Initial Statement of Beneficial Ownership
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload